Using current evidence in selecting antiepileptic drugs for use during pregnancy
- PMID: 16059433
- PMCID: PMC1176305
- DOI: 10.1111/j.1535-7597.2005.05201.x
Using current evidence in selecting antiepileptic drugs for use during pregnancy
Abstract
Children born to mothers taking antiepileptic drugs (AEDs) are at increased risk for findings of fetal anticonvulsant syndrome. Accepted treatment paradigms to minimize fetal risks include use of AED monotherapy and folic acid supplementation. However, as data are acquired from several ongoing pregnancy registries, differential risks among the various AED monotherapy regimens are being defined, further improving fetal outcomes.
Figures
References
-
- Yerby MS. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology. 2000;55:21–31. - PubMed
-
- Stumpf D, Frost M. Seizures, anticonvulsants, and pregnancy. Am J Dis Child. 1978;132:746–748. - PubMed
-
- Minkoff H, Schaffer R, Delke I, Grunevaum A. Diagnosis of intracranial hemorrhage in utero after a maternal seizure. Obstet Gynecol. 1985;65(suppl):22S–24S. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources